Drug Database
Back to search

Netherlands· NL-184128ecb79c

Ethinylestradiol 0,035 mg /Cyproteronacetaat 2 mg, omhulde tabletten

A cyproteron und estrogen product containing cyproteronacetaat + ethinylestradiol, registered in Netherlands by Stragen France. The same ATC class is registered in 11 of our 19 countries.

ATC G03HB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEthinylestradiol 0,035 mg /Cyproteron…ATCG03HB01REGISTER NO.NL-184128ecb79cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cyproteronacetaat + ethinylestradiolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cyproteron und estrogen is registered in 11 of 19 countries.

Countries holding a registration under ATC G03HB01 (cyproteron und estrogen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search cyproteron und estrogen products by name

Cyproteron und estrogen · ATC G03HB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CYPROTERONACETAAT + ETHINYLESTRADIOL
Manufacturer
Stragen France
Country
Netherlands (NL)
ATC code
G03HB01
ATC class
Cyproteron und Estrogen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29728

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

32 interactions on record for cyproteron und estrogen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cyproteron und estrogen against other medicinesHow interaction checks work

Cyproteron und estrogen · interactions on record

32 records

32 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Cyproteron und estrogen in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyproteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Alisma, Bellgyn
  • Belgium · Daphne, Diane-35
  • Czechia · Minerva, Vreya
  • Germany · Attempta, Bella
  • Denmark · Vreya, Zyrona
  • Finland · Cypretyl, Diane Nova
  • France · Diane, Evepar
  • United Kingdom (Northern Ireland) · Camilette, Clairette
  • Croatia · Axira 35, Diane
  • Hungary · Cypromix
  • Ireland · Dianette
  • Italy · Diane, Visofid
  • Luxembourg · Daphne, Diane-35
  • Malta · Vreya
  • Norway · Zyrona
  • Poland · Cyprodiol, Diane-35
  • Portugal · Ciproterona + Etinilestradiol Generis, Diane 35
  • Romania · Diane-35
  • Sweden · Zyrona
  • Slovakia · Vreya

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f60e4ce5-c031-4140-9fbe-34aabb55e76f
GET /v1/drugs/f60e4ce5-c031-4140-9fbe-34aabb55e76f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Omhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29728_smpc.pdf",
  "strength": null,
  "atc_label": "Cyproterone And Estrogen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29728",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "GLYCEROL 85 PER CENT (E 422)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "MONTAANGLYCOLWAS (E 912)",
    "POVIDON K 25 (E 1201)",
    "POVIDON K 90 (E 1201)",
    "SACCHAROSE",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CYPROTERONACETAAT",
    "ETHINYLESTRADIOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29728.pdf",
  "authorised_at": "2004/12/20",
  "procedure_number": "NL/H/0623/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29728",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about cyproteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console